The financial position of HCL and the HCL Group
30 HCL was listed on the Australian Securities Exchange (the ASX) on 21 December 2006. At that time, its share price was approximately $0.60. As at 18 February 2010, its share price was $0.04.
31 HCL and the entities controlled by it (collectively, the HCL Group) are consolidated for tax and accounting purposes.
32 HCL Group's Financial Report for the year ended 30 June 2009 (the 2009 Financial Report), states that the HCL Group incurred a net loss before income tax of $1,945,590. A slightly smaller net loss before income tax of $1,634,239 was recorded for the previous financial year. The balance sheet for the HCL Group as at 30 June 2009 shows that, during the year, the group had been involved in substantial borrowing and had a deficiency of net assets of $8,790.
33 Despite the financial performance described above, the 2009 Financial Report states:
The Directors [of HCL] nevertheless believe that its [sic] is appropriate to prepare the financial report on a going concern basis because: -
a) Following a recent restructure, the company is transitioning towards profitability and positive cash flows.
b) The company has recently introduced new income streams and exploring [sic] other avenues to increase revenue.
c) The ability to meet operating expenditure is also dependant upon future fundraising and/or the company's business opportunities generating positive cash flows.
34 An independent auditor's report to the members of HCL prepared by Drew Townsend of Hall Chadwick Chartered Accountants, which was attached to the 2009 Financial Report, stated that the net loss and deficiency of net assets indicated "the existence of a material uncertainty which may cast doubt about the group's ability to continue as a going concern."
35 On 30 October 2009, HCL released its Quarterly Report for the period ended 30 September 2009 (the September Quarterly Report). The report showed that the HCL Group had total operating and investing cash flows of (negative) $371,000 for the quarter. The HCL Group incurred a net decrease in cash held of $271,000. The HCL Group's cash at the end of the quarter was $619,000, with borrowings for the quarter of $100,000.
36 Following the release of the September Quarterly Report, the ASX wrote to HCL requesting responses to a number of questions relating to that report. The request was sent by letter dated 9 November 2009. Relevantly, the letter stated:
1. It is possible to conclude on the basis of the information provided that if [HCL] were to continue to expend cash at the rate for the quarter indicated by [the September Quarterly Report], [HCL] may only have sufficient cash to fund its activities for less than 2 quarters. Is this the case, or are there other factors that should be taken into account in assessing [HCL's] position?
37 HCL responded in a letter dated 13 November 2009 that was signed by Mr Lee. In response to the question set out above, Mr Lee stated:
1. While assessing [HCL's] Quarterly Report… submitted to the ASX on 30 October 2009, there are additional factors that the reader should take into consideration while assessing [HCL's] position. Firstly, [HCL] has developed additional revenue streams from the pharmacy management model and Chemconsult which have broadened the revenue base of [HCL] and are now starting to provide [HCL] with additional revenue over what has been achieve [sic] in previous quarters. [HCL] also continues to hold discussions with a number of major industry players about the rapid expansion of Chemconsult. Secondly, [HCL] has implemented an organisation restructure and cost cutting program designed to ensure that the cost base of the business is substantially below the anticipated revenue streams that are developing. Thirdly, [HCL] continues it [sic] efforts to raise additional funding by way of Convertible Notes and is in discussions with a number of potential investors. These three measures are designed to provide [HCL] with additional working capital and revenue which will see [HCL] expand in the future.
38 On 29 January 2010, HCL released its Quarterly Report for the period ended 31 December 2009 (the December Quarterly Report). The report showed that the HCL Group had total operating and investing cash flows of (negative) $323,000 for the quarter. The HCL Group incurred a net decrease in cash held of $118,000. The HCL Group's cash at the end of the quarter was $500,000 with borrowings for the quarter of $205,000.
39 The Chairman's Report 2009 addressed to "shareholders and members" states:
Health Corporation's losses being no exception over the past year were not entirely anticipated. Primarily, this result is attributable to final provisioning outlays for the subsidiary financing arm of the Company, Leverage Finance.
40 On 1 February 2010 the ASX wrote to HCL requesting responses to a number of questions arising from the December Quarterly Report. Once again the letter asked:
1. It is possible to conclude on the basis of the information provided that if [HCL] were to continue to expend cash at the rate for the quarter indicated by [the December Quarterly Report], [HCL] may only have sufficient cash to fund its activities for less than 2 quarters. Is this the case, or are there other factors that should be taken into account in assessing [HCL's] position?
41 HCL responded by letter dated 2 February 2009. In the letter Mr Lee addressed that question in similar terms to those set out in paragraph 37above.
42 HCL's Interim Financial Report for the half-year period ending 31 December 2009 (the Interim Financial Report) was lodged with the ASX on 1 March 2010. The report shows that as at 31 December 2009, the HCL Group had incurred a net loss of $1,070,287 for the period, and that its current liabilities exceeded its current assets by $2,304,842. The report included the following statement:
As at 31 December 2009, [HCL] incurred a loss of $1,070,287. The Financial Report has been prepared on a going concern basis as the Directors believe it is appropriate. This opinion is based upon the projected future profits and negotiations with various parties who are prepared to invest in [HCL]. In the event that [HCL] will not be able to earn future profits as stated in its current projections, and negotiations with various parties fail to materialise, the Directors will consider a further capital raising.
43 An Independent Auditor's Review Report to Members dated 26 February 2010, based on the Interim Financial Report, was prepared by Mr Townsend (the Review Report). The Review Report noted that the Interim Financial Report had been prepared on a "going concern" basis. It also noted the Directors' opinion quoted above. Mr Townsend said:
In Note 1 to the half year financial report, the directors state their opinion that the going concern basis used in the preparation of the half year financial report is appropriate. This opinion is based on projected profits and negotiations with various parties who are prepared to invest in the company. In our opinion these circumstances are unlikely to eventuate and indicate the existence of a material uncertainty which may cast significant doubt on the company's ability to continue as a going concern and therefore it may be unable to realise its assets and discharge its liabilities in the normal course of business and at the amounts stated in the financial report.
44 The Review Report concluded:
…[T]he half year financial report of Health Corporation Limited and Controlled Entities is not in accordance with the Corporations Act 2001 and does not:
a. give a true and fair view of the company's financial position as at 31 December 2009 and of its performance for the half year ended on that date; and
b. comply with Accounting Standard AASB 134 Interim Financial Reporting and the Corporations Regulations 2001.
45 In his affidavit affirmed on 22 February 2010 Mr Lee said that the losses incurred for the financial year ended 30 June 2009, as set out in the 2009 Financial Report, would not have the effect of rendering the applicant incapable of performing its obligations under its franchise agreements. He said that, on the float, HCL had a market capitalisation of some $28 million and that, even with the decline in share price to $0.04, it still had a market capitalisation of some $2 million.
46 The respondents submitted, correctly in my view, that the market capitalisation of HCL is irrelevant to the present question of the applicant's ability to meet an adverse costs order in this proceeding.
47 Mr Lee also said that the losses incurred by HCL as recorded in the September Quarterly Report and the December Quarterly Report were primarily related to bad debt provisions, staff redundancies and other cost cutting measures, and will not be ongoing. He said that the redundancies and cost cutting measures have had the effect of reducing HCL's monthly operating costs by approximately $70,000 per month. He said that he expected "the third quarter of this financial year to break-even, or near break-even."
48 Mr Lee also said that he expected HCL to continue to have around $500,000 cash at the end of the third quarter of the present financial year, and that this would be more than adequate provision to meet any adverse costs order made against the applicant.
49 The respondents submitted that the fact that the HCL Group had cash assets of approximately $500,000 as at 31 December 2009 did not remove the risk that the applicant will be unable to meet an adverse costs order (on the assumption that HCL and the applicant are treated as one). They submitted that any cash held by the HCL Group must be considered in light of the group's overall negative equity. Therefore, it is likely that some or all of the cash assets will be required to meet existing liabilities. Moreover, given the losses sustained by the HCL Group in the six months to 31 December 2009, it could not be assumed that any cash currently held by the HCL Group would be available in the future to meet an adverse costs order. In this regard the respondents submitted that it was notable that the HCL Group's independent auditor had expressed the view that the profits projected and negotiations with various parties who were prepared to invest in HCL, as mentioned in the Interim Financial Report, were circumstances that were "unlikely to eventuate". I accept these submissions.